New patent for Gilead Sciences drug STRIBILD

Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from five suppliers. There are sixteen…

The post New patent for Gilead Sciences drug STRIBILD appeared first on DrugPatentWatch.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: